Sharp India

< -5%

-5% to -3%

Arham Tech

EPack Durables

GNG Electronics

Wonder Elect.

Salora Inter

-3% to 0%

Prizor Viztech

Honeywell Autom

Dixon Technolog

0% to 3%

Emmforce

Thakral Service

3% to 5%

Cellecor

The shares of SBI Cards and Zen Technologies dropped in trade on October 27 after the second quarter earnings for the credit card issuer and defence player failed to meet expectations. SBI Cards shares fell more than 4 percent, while Zen Tech shares plunged nearly 7 percent.

SBI Cards shares were trading at Rs 890.40 apiece, while Zen Tech shares were trading at Rs 1,305 apiece in the early trading hours of Monday.

SBI Cards Q2 Results:

<a href="https://www.moneycontrol.com/india/stockpricequote/finance-term-lending/sbicardspaymentservices/SCP02">SBI Cards and Payment Services</a> reported a net profit of Rs 445 crore for the July-September quarter of the financial year 2026. This marked a nearly 10 percent year-on-year increase from the Rs 404 crore net profit reported in the corresponding quarter of the previous financial year.

The firm's revenue from operations meanwhile rose more than 12 percent YoY to Rs 4,961 crore during the quarter under review. It had earlier reported revenue from operations at Rs 4,421 crore during the same period last year.

Macquarie on SBI Cards:

Macquarie kept a 'Neutral' call on the stock, with a target price of Rs 990 per share. This implies an upside potential of nearly 7 percent from the stock's previous closing price. The international brokerage said that the firm's profit after tax missed estimates, driven by higher operating expenditure.

It noted that all eyes are currently on the credit cost trajectory. Macquarie expects the firm's net interest margin to improve in the coming quarters. It noted that the stock appears expensive at 4.5x FY27 P/B for an RoA trajectory of 3 percent (H1 FY26).

Jefferies on SBI Cards:

Jefferies kept a 'Hold' call on the stock, with a target price of Rs 1,010 per share. This implies an upside potential of nearly 9 percent from the stock's previous closing price.

The international brokerage noted that the Q2 profit after tax was below estimate on lower NIM and fee income, as well as slightly higher operating expenditure. The firm's most asset quality metrics improved sequentially, which indicates that the stress is abating, Jefferies added.

The brokerage however said that asset growth outlook stays modest and fee income pressure should persist. It has cut FY26-27 EPS by 7-14 percent.

Nuvama on SBI Cards:

Nuvama meanwhile downgraded SBI Cards shares to 'Hold', with a target price of Rs 1,025 per share. This implies an upside potential of more than 10 percent from the stock's previous closing price. The international brokerage noted that the strong growth in Q2 retail spends (9 percent QoQ) and receivables (6 percent QoQ) was boosted by festive demand.

However, NIM, fees, opex and credit cost missed consensus, Nuvama added. NIM stayed flat QoQ despite a 51 bps YoY decline in CoF due to a higher share of transactors, while credit cost contracted 4 percent QoQ to 9 percent, but missed consensus by 5 percent, the brokerage added.

It noted that the company's management has guided that credit cost would fall below 9 percent in FY26. It added that the stock is trading at 40x/27x Pe Fy26e/27e, leaving no room for upside.

Zen Tech Q2 Results:

<a href="https://www.moneycontrol.com/india/stockpricequote/defence/zentechnologies/ZT01">Zen Technologies</a> on October 25 reported a net profit of Rs 59.40 crore for the second quarter of the ongoing financial year 2026. This marks a 4.6 percent YoY drop from the Rs 62.27 crore net profit reported in Q2 FY25.

The defence player's revenue from operations meanwhile dropped more than 28 percent YoY to Rs 173.57 crore in Q2 FY26. The company had earlier reported revenue from operations at Rs 241.84 crore for Q2 FY25.

Motilal Oswal on Zen Tech:

Motilal Oswal remained 'Neutral' on the stock. The domestic brokerage said that the company reported a weak set of numbers in Q2 FY26 with a miss on revenue and EBITDA, although PAT beat its estimates.

Also read: <a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-sensex-nifty-50-share-price-gift-nifty-latest-updates-27-10-2025-liveblog-13632956.html">Our LIVE blog on stock market updates</a>

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

Ownership, Material Conflicts of Interest and Disciplinary History

MCD is a wholly owned subsidiary of Network 18 Media & Investments Ltd ("Network18"), in which Independent Media Trust (IMT) holds 56.89% stake. Reliance Industries Limited ("RIL") is the sole beneficiary of IMT. Network18 and RIL and their subsidiaries, joint ventures and associates can be considered as associates of MCD.

Details of Associate

Receipt of Compensation

Third-Party Compensation

Employment History

Market-Making Activities

Use of Artificial Intelligence

Q2 Results impact: SBI Cards shares drop 4% after Sept quarter earnings miss estimates, Zen Tech down 7%

The shares of SBI Cards and Zen Technologies dropped in trade on October 27 after the second quarter earnings for the credit card issuer and defence player failed to meet expectations. SBI Cards shares fell more than 4 percent, while Zen Tech shares plunged nearly 7 percent.

SBI Cards shares were trading at Rs 890.40 apiece, while Zen Tech shares were trading at Rs 1,305 apiece in the early trading hours of Monday.

SBI Cards Q2 Results:

SBI Cards and Payment Services reported a net profit of Rs 445 crore for the July-September quarter of the financial year 2026. This marked a nearly 10 percent year-on-year increase from the Rs 404 crore net profit reported in the corresponding quarter of the previous financial year.

The firm's revenue from operations meanwhile rose more than 12 percent YoY to Rs 4,961 crore during the quarter under review. It had earlier reported revenue from operations at Rs 4,421 crore during the same period last year.

Macquarie on SBI Cards:

Macquarie kept a 'Neutral' call on the stock, with a target price of Rs 990 per share. This implies an upside potential of nearly 7 percent from the stock's previous closing price. The international brokerage said that the firm's profit after tax missed estimates, driven by higher operating expenditure.

It noted that all eyes are currently on the credit cost trajectory. Macquarie expects the firm's net interest margin to improve in the coming quarters. It noted that the stock appears expensive at 4.5x FY27 P/B for an RoA trajectory of 3 percent (H1 FY26).

Jefferies on SBI Cards:

Jefferies kept a 'Hold' call on the stock, with a target price of Rs 1,010 per share. This implies an upside potential of nearly 9 percent from the stock's previous closing price.

The international brokerage noted that the Q2 profit after tax was below estimate on lower NIM and fee income, as well as slightly higher operating expenditure. The firm's most asset quality metrics improved sequentially, which indicates that the stress is abating, Jefferies added.

The brokerage however said that asset growth outlook stays modest and fee income pressure should persist. It has cut FY26-27 EPS by 7-14 percent.

Nuvama on SBI Cards:

Nuvama meanwhile downgraded SBI Cards shares to 'Hold', with a target price of Rs 1,025 per share. This implies an upside potential of more than 10 percent from the stock's previous closing price. The international brokerage noted that the strong growth in Q2 retail spends (9 percent QoQ) and receivables (6 percent QoQ) was boosted by festive demand.

However, NIM, fees, opex and credit cost missed consensus, Nuvama added. NIM stayed flat QoQ despite a 51 bps YoY decline in CoF due to a higher share of transactors, while credit cost contracted 4 percent QoQ to 9 percent, but missed consensus by 5 percent, the brokerage added.

It noted that the company's management has guided that credit cost would fall below 9 percent in FY26. It added that the stock is trading at 40x/27x Pe Fy26e/27e, leaving no room for upside.

Zen Tech Q2 Results:

Zen Technologies on October 25 reported a net profit of Rs 59.40 crore for the second quarter of the ongoing financial year 2026. This marks a 4.6 percent YoY drop from the Rs 62.27 crore net profit reported in Q2 FY25.

The defence player's revenue from operations meanwhile dropped more than 28 percent YoY to Rs 173.57 crore in Q2 FY26. The company had earlier reported revenue from operations at Rs 241.84 crore for Q2 FY25.

Motilal Oswal on Zen Tech:

Motilal Oswal remained 'Neutral' on the stock. The domestic brokerage said that the company reported a weak set of numbers in Q2 FY26 with a miss on revenue and EBITDA, although PAT beat its estimates.

Also read: Our LIVE blog on stock market updates

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

The shares of <a href="https://www.moneycontrol.com/india/stockpricequote/computers-software/coforge/NII02">Coforge</a> jumped more than 6 percent on October 27 after the company released better-than-expected results for the second quarter of the financial year 2026. Brokerages have raised target prices for the stock, anticipating strong upside potential from the current levels.

The shares of the IT company were trading at Rs 1,866.60 apiece in the early trading hours of Monday. The stock is currently the top gainer of the Nifty IT index, which itself is up around half a percent. The company had released its results in the post market hours of October 24.

Coforge Q2 Results:

Coforge reported a consolidated net profit of Rs 376 crore for the July-September quarter of the financial year 2026. This marks a 77.5 percent year-on-year jump from the Rs 212 crore net profit reported in the same period of the previous financial year.

The firm’s revenue from operations meanwhile grew around 32 percent YoY to Rs 3,985.7 crore in Q2 FY26, from Rs 3,025.6 crore in Q2 FY25.

Along with the Q2 results, Coforge announced a second interim dividend of Rs 4 per equity share for the ongoing financial year 2026. The company has fixed October 31 as the record date to determine the eligibility of the shareholders set to receive the payment.

Morgan Stanley on Coforge:

Morgan Stanley held an ‘overweight’ call on the stock, while raising its target price to Rs 2,030 per share. This implies an upside potential of more than 15 percent from the stock’s previous closing price of Rs 1,760 per share. The international brokerage noted that Coforge delivered an all-round performance in Q2, allaying investor concerns.

The firm sees good visibility in the second half of the financial year in terms of both growth and margins. Beyond FY26, Coforge’s intent is to keep firing on revenue growth, Morgan Stanley added.

JPMorgan on Coforge:

JPMorgan also held an ‘overweight’ call on the stock, with a target price of Rs 2,500 per share. This implies an upside potential of more than 42 percent from the stock’s previous closing price. The international brokerage said that the company needed to deliver on margins and cash flows after facing challenges last time, and it did exactly that with margin at 14 percent beating the brokerage’s estimates by 50 basis points.

JPMorgan said that the firm’s 5.9 percent QoQ revenue growth in CC terms came broadly in-line with expectations. It however noted that the deal TCV continued to remain below the $500 million-mark for the fifth consecutive quarter.

The international brokerage noted that the management has highlighted that demand has improved somewhat, and expects H2 growth to be robust on the back of strong deal wins and pipeline. The firm’s management continues to target 14 percent EBIT margins for FY26.

Nuvama on Coforge:

Nuvama kept a ‘Buy’ call on Coforge, while raising the target price to Rs 2,250 per share. This implies an upside potential of nearly 28 percent from the stock’s previous closing price. The international brokerage said that the firm has yet again delivered a robust performance in Q2.

Also read: <a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-sensex-nifty-50-share-price-gift-nifty-latest-updates-27-10-2025-liveblog-13632956.html">Our LIVE blog on stock market updates</a>

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

Coforge shares jump 6% as brokerages raise target prices following better-than-expected Q2 results

The shares of Coforge jumped more than 6 percent on October 27 after the company released better-than-expected results for the second quarter of the financial year 2026. Brokerages have raised target prices for the stock, anticipating strong upside potential from the current levels.

The shares of the IT company were trading at Rs 1,866.60 apiece in the early trading hours of Monday. The stock is currently the top gainer of the Nifty IT index, which itself is up around half a percent. The company had released its results in the post market hours of October 24.

Coforge Q2 Results:

Coforge reported a consolidated net profit of Rs 376 crore for the July-September quarter of the financial year 2026. This marks a 77.5 percent year-on-year jump from the Rs 212 crore net profit reported in the same period of the previous financial year.

The firm’s revenue from operations meanwhile grew around 32 percent YoY to Rs 3,985.7 crore in Q2 FY26, from Rs 3,025.6 crore in Q2 FY25.

Along with the Q2 results, Coforge announced a second interim dividend of Rs 4 per equity share for the ongoing financial year 2026. The company has fixed October 31 as the record date to determine the eligibility of the shareholders set to receive the payment.

Morgan Stanley on Coforge:

Morgan Stanley held an ‘overweight’ call on the stock, while raising its target price to Rs 2,030 per share. This implies an upside potential of more than 15 percent from the stock’s previous closing price of Rs 1,760 per share. The international brokerage noted that Coforge delivered an all-round performance in Q2, allaying investor concerns.

The firm sees good visibility in the second half of the financial year in terms of both growth and margins. Beyond FY26, Coforge’s intent is to keep firing on revenue growth, Morgan Stanley added.

JPMorgan on Coforge:

JPMorgan also held an ‘overweight’ call on the stock, with a target price of Rs 2,500 per share. This implies an upside potential of more than 42 percent from the stock’s previous closing price. The international brokerage said that the company needed to deliver on margins and cash flows after facing challenges last time, and it did exactly that with margin at 14 percent beating the brokerage’s estimates by 50 basis points.

JPMorgan said that the firm’s 5.9 percent QoQ revenue growth in CC terms came broadly in-line with expectations. It however noted that the deal TCV continued to remain below the $500 million-mark for the fifth consecutive quarter.

The international brokerage noted that the management has highlighted that demand has improved somewhat, and expects H2 growth to be robust on the back of strong deal wins and pipeline. The firm’s management continues to target 14 percent EBIT margins for FY26.

Nuvama on Coforge:

Nuvama kept a ‘Buy’ call on Coforge, while raising the target price to Rs 2,250 per share. This implies an upside potential of nearly 28 percent from the stock’s previous closing price. The international brokerage said that the firm has yet again delivered a robust performance in Q2.

Also read: Our LIVE blog on stock market updates

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticalsdrugs/zyduslifesciences/CHC">Zydus Lifesciences</a> share price remained unchanged in the opening trade on October 27 following the NOC (Notice of Compliance) from Health Canada for generic Mesalamine suppositories 1000 mg.

At 09:24am, Zydus Lifesciences was quoting at Rs 1,004.95, down Rs 0.70, or 0.07 percent, on the BSE.

Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis.

ZDS - Mesalamine suppositories will be manufactured at company's Changodar, Ahmedabad in Gujarat, India.

<a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-sensex-nifty-50-share-price-gift-nifty-latest-updates-27-10-2025-liveblog-13632956.html">Catch all the market action on our live blog</a>

Earlier in this month, the company received NOC from Health Canada for generic Liothyronine tablets 5 mcg and 25 mcg, use for treating hypothyroidism.

Also, received final approval from the United States Food and Drug Administration (USFDA) for Deflazacort oral suspension.

In the previous trading session, the share closed at Rs 1,005.65, down Rs 2.15, or 0.21 percent.

The share touched a 52-week high of Rs 1,059.00 and a 52-week low of Rs 797.05 on 19 September, 2025 and 07 April, 2025, respectively.

Currently, the stock is trading 5.1 percent below its 52-week high and 26.08 percent above its 52-week low.

The market capitalisation of the company stands at Rs 101,121.48 crore.

Zydus Lifesciences gets Health Canada approval, share price unchange

Zydus Lifesciences share price remained unchanged in the opening trade on October 27 following the NOC (Notice of Compliance) from Health Canada for generic Mesalamine suppositories 1000 mg.

At 09:24am, Zydus Lifesciences was quoting at Rs 1,004.95, down Rs 0.70, or 0.07 percent, on the BSE.

Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis.

ZDS - Mesalamine suppositories will be manufactured at company's Changodar, Ahmedabad in Gujarat, India.

Catch all the market action on our live blog

Earlier in this month, the company received NOC from Health Canada for generic Liothyronine tablets 5 mcg and 25 mcg, use for treating hypothyroidism.

Also, received final approval from the United States Food and Drug Administration (USFDA) for Deflazacort oral suspension.

In the previous trading session, the share closed at Rs 1,005.65, down Rs 2.15, or 0.21 percent.

The share touched a 52-week high of Rs 1,059.00 and a 52-week low of Rs 797.05 on 19 September, 2025 and 07 April, 2025, respectively.

Currently, the stock is trading 5.1 percent below its 52-week high and 26.08 percent above its 52-week low.

The market capitalisation of the company stands at Rs 101,121.48 crore.

<a href="https://www.moneycontrol.com/india/stockpricequote/constructioncontracting-civil/gptinfraprojects/GPT01">GPT Infraprojects</a> share price surged nearly 13 percent in the opening trade on October 27 following the company received contract of Rs 195 crore.

At 09:23 hrs GPT Infraprojects was quoting at Rs 117.45, up Rs 13.40, or 12.88 percent, on the BSE.

Terminal Industriel Polyvalent de San Pedro, Ivory Coast has awarded the contract for supply and installation, testing and commissioning of conveyor belt system in the port of Ivory Coast, to be executed in 12 months.

<a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-sensex-nifty-50-share-price-gift-nifty-latest-updates-27-10-2025-liveblog-13632956.html">Catch all the market action on our live blog</a>

In the previous trading session, the share closed at Rs 104.05, down Rs 0.60, or 0.57 percent.

The share touched a 52-week high of Rs 153.05 and a 52-week low of Rs 84.75 on 29 November, 2024 and 05 March, 2025, respectively.

Currently, the stock is trading 23.26 percent below its 52-week high and 38.58 percent above its 52-week low.

The market capitalisation of the company stands at Rs 1,484.15 crore.

GPT Infraprojects shares surge nearly 13% on order win of Rs 195 crore

GPT Infraprojects share price surged nearly 13 percent in the opening trade on October 27 following the company received contract of Rs 195 crore.

At 09:23 hrs GPT Infraprojects was quoting at Rs 117.45, up Rs 13.40, or 12.88 percent, on the BSE.

Terminal Industriel Polyvalent de San Pedro, Ivory Coast has awarded the contract for supply and installation, testing and commissioning of conveyor belt system in the port of Ivory Coast, to be executed in 12 months.

Catch all the market action on our live blog

In the previous trading session, the share closed at Rs 104.05, down Rs 0.60, or 0.57 percent.

The share touched a 52-week high of Rs 153.05 and a 52-week low of Rs 84.75 on 29 November, 2024 and 05 March, 2025, respectively.

Currently, the stock is trading 23.26 percent below its 52-week high and 38.58 percent above its 52-week low.

The market capitalisation of the company stands at Rs 1,484.15 crore.

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, appointments and order wins, here’s a quick look at which stocks will be in focus in today's trade:

<a href="https://www.moneycontrol.com/markets/earnings/" target="_blank">Results Today</a>

Indus Towers, Indian Oil Corporation, Adani Energy Solutions, Bata India, Canara HSBC Life Insurance Company, Canara Robeco Asset Management Company, Chennai Petroleum Corporation, Glottis, JK Tyre &amp; Industries, KFin Technologies, Mahindra Logistics, Mazagon Dock Shipbuilders, PNB Housing Finance, Raymond, Sona BLW Precision Forgings, SRF, Supreme Industries, Tata Investment Corporation, Tamil Nadu Newsprint &amp; Papers, and Welspun Specialty Solutions will release their quarterly earnings today.

<a href="https://www.moneycontrol.com/markets/earnings/" target="_blank">Quarterly Earnings</a>

<a href="https://www.moneycontrol.com/india/stockpricequote/banks-private-sector/kotakmahindrabank/KMB" target="_blank">Kotak Mahindra Bank</a> Q2 (Standalone YoY)

Profit falls 2.7% to Rs 3,253.3 crore Vs Rs 3,343.7 crore

Net interest income rises 4.1% to Rs 7,310.7 crore Vs Rs 7,019.6 crore

Provisions and contingencies spike 43.5% to Rs 947.4 crore Vs Rs 660.4 crore

Gross NPA drops to 1.39% Vs 1.48% (QoQ)

Net NPA declines to 0.32% Vs 0.34% (QoQ)

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/drreddyslaboratories/DRL" target="_blank">Dr Reddy's Laboratories</a> Q2 (Consolidated YoY)

Profit grows 14.5% to Rs 1,437.2 crore Vs Rs 1,255.3 crore

Revenue increases 9.8% to Rs 8,805.1 crore Vs Rs 8,016.2 crore

North America business drops 13.1% to Rs 3,240.8 crore Vs Rs 3,728.1 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/lifehealth-insurance/sbilifeinsurancecompany/SLI03" target="_blank">SBI Life Insurance Company</a> Q2 (YoY)

Profit declines 6.6% to Rs 494.6 crore Vs Rs 529.4 crore

Net premium income soars 22.6% to Rs 24,848.3 crore Vs Rs 20,266.1 crore

Net commission surges 22.2% to Rs 1,240.3 crore Vs Rs 1,014.8 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/computers-software/coforge/NII02" target="_blank">Coforge</a> Q2 (Consolidated YoY)

Profit zooms 86% to Rs 375.8 crore Vs Rs 202.1 crore

Revenue surges 31.7% to Rs 3,985.7 crore Vs Rs 3,025.6 crore

Board declares interim dividend of Rs 4 per share

<a href="https://www.moneycontrol.com/india/stockpricequote/defence/zentechnologies/ZT01" target="_blank">Zen Technologies</a> Q2 (Consolidated YoY)

Profit falls 4.6% to Rs 59.4 crore Vs Rs 62.3 crore

Revenue drops 28.2% to Rs 173.6 crore Vs Rs 241.8 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/it-servicesconsulting/latentviewanalytics/LVA" target="_blank">Latent View Analytics</a> Q2 (Consolidated YoY)

Profit grows 11.3% to Rs 44.4 crore Vs Rs 39.9 crore

Revenue increases 23.3% to Rs 257.5 crore Vs Rs 209 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticalsdrugs/sigachiindustries/SIL19" target="_blank">Sigachi Industries</a> Q2 (Consolidated YoY)

Profit sinks 50.9% to Rs 10.7 crore Vs Rs 21.8 crore

Revenue declines 11.5% to Rs 110.5 crore Vs Rs 124.9 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/petrochemicals/supremepetrochem/SP" target="_blank">Supreme Petrochem</a> Q2 (Standalone YoY)

Profit plunges 46.6% to Rs 48.2 crore Vs Rs 90.3 crore

Revenue drops 26.9% to Rs 1,100.2 crore Vs Rs 1,505.6 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/finance-term-lending/sbicardspaymentservices/SCP02" target="_blank">SBI Cards and Payment Services</a> Q2 (YoY)

Profit rises 10% to Rs 444.8 crore Vs Rs 404.4 crore

Revenue increases 12.2% to Rs 4,961 crore Vs Rs 4,421 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/computers-software-mediumsmall/eclerxservices/eS06" target="_blank">eClerx Services</a> Q2 (Consolidated YoY)

Profit zooms 30.6% to Rs 183.2 crore Vs Rs 140.2 crore

Revenue jumps 20.8% to Rs 1,004.9 crore Vs Rs 831.8 crore

Board approves buyback of 6.66 lakh shares worth up to Rs 300 crore at Rs 4,500 per share

Stocks to Watch

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticalsdrugs/zyduslifesciences/CHC" target="_blank">Zydus Lifesciences</a>

The company has received a Notice of Compliance (NOC) from Health Canada for generic Mesalamine suppositories 1000 mg. Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis.

Meanwhile, the company’s subsidiary Zydus MedTech France has acquired the remaining 14.4% share capital in Amplitude Surgical SA, France, through a mandatory tender offer and squeeze-out. As a result, Zydus MedTech France now holds 100% of the share capital in Amplitude Surgical.

<a href="https://www.moneycontrol.com/india/stockpricequote/chemicals/tgvsraac/SRA" target="_blank">TGV Sraac</a>

Due to the failure of winding in a transformer supplied by Transformers and Rectifiers India, the company is expecting an estimated loss of production of 120 TPD of caustic soda and 106 TPD of chlorine.

It is further expected that the transformer will be restored within 60 days. The company is also exploring other alternatives for restoration.

<a href="https://www.moneycontrol.com/india/stockpricequote/constructioncontracting-civil/ncc/NCC01" target="_blank">NCC</a>

The company has received a Letter of Acceptance for a contract worth Rs 6,828.94 crore from Central Coalfields for the extraction and transportation of overburden (OB) and coal at Amrapali OCP, Chandragupt Area, Jharkhand.

<a href="https://www.moneycontrol.com/india/stockpricequote/constructioncontracting-civil/gptinfraprojects/GPT01" target="_blank">GPT Infraprojects</a>

The company has received an order worth Rs 195 crore from Terminal Industriel Polyvalent de San Pedro, Ivory Coast, for the supply, installation, testing, and commissioning of a conveyor belt system at the Ivory Coast port.

<a href="https://www.moneycontrol.com/india/stockpricequote/engineeringconstruction/epackprefabtechnologies/EPTL" target="_blank">Epack Prefab Technologies</a>

The company has received an order worth Rs 129.94 crore from Avaada Ventures. The order involves the design, fabrication, and supply of a pre-engineered steel building for a glass factory at Butibori, Nagpur, Maharashtra.

<a href="https://www.moneycontrol.com/india/stockpricequote/engineering-construction/vikranengineering/VEL01" target="_blank">Vikran Engineering</a>

The company has received a Letter of Award for a contract worth Rs 354.21 crore from Ellume Energy MH SolarOne (SPV) for the development of a 100 MW (AC) cumulative capacity grid-interactive solar PV power project in Maharashtra.

<a href="https://www.moneycontrol.com/india/stockpricequote/constructioncontracting-real-estate/housingurbandevelopmentcorporation/HUD" target="_blank">Housing &amp; Urban Development Corporation</a>

HUDCO has signed a non-binding Memorandum of Understanding (MoU) with the Jawaharlal Nehru Port Authority (JNPA) to explore collaboration in existing and upcoming infrastructure development, and in financing and refinancing of port infrastructure projects at JN Port, for an estimated amount of Rs 5,000 crore.

<a href="https://www.moneycontrol.com/india/stockpricequote/refineries/relianceindustries/RI" target="_blank">Reliance Industries</a>

The company’s subsidiary Reliance Intelligence has incorporated Reliance Enterprise Intelligence (REIL). REIL will become a joint venture company as per the amended and restated joint venture agreement with Facebook Overseas, Inc., a wholly owned subsidiary of Meta Platforms, Inc.

As per the JV agreement, Reliance Intelligence will hold 70%, and Facebook will hold the remaining 30% in REIL. Both companies have jointly committed an initial investment of Rs 855 crore.

<a href="https://www.moneycontrol.com/india/stockpricequote/diversified/generalinsurancecorporationindia/GIC12" target="_blank">General Insurance Corporation of India</a>

The Ministry of Finance has approved the entrustment of financial and administrative powers and functions of the Chairman-cum-Managing Director (CMD) of GIC Re to Hitesh Ramesh Chandra Joshi, currently the Executive Director of the company, effective October 1, for a period of three months.

<a href="https://www.moneycontrol.com/india/stockpricequote/transportlogistics/containercorporationindia/CCI" target="_blank">Container Corporation of India</a>

The company has entered into two strategic Memorandums of Understanding (MoUs) with Adani Cement to focus on the rail-based transportation of bulk cement using specialised tank containers.

<a href="https://www.moneycontrol.com/india/stockpricequote/constructioncontracting-real-estate/puravankara/PP01" target="_blank">Puravankara</a>

The company’s subsidiary Starworth Infrastructure &amp; Construction has received a Letter of Award worth Rs 211.53 crore for the construction of core and shell works with finishes for the proposed residential project “SBR Global Queen’s Ville” for SBR Builders.

<a href="https://www.moneycontrol.com/india/stockpricequote/telecommunications-services/railtelcorporationindia/RCo01" target="_blank">RailTel Corporation of India</a>

Due to unavoidable reasons, the Bihar Education Project Council has cancelled the work order worth Rs 209.78 crore.

On September 13, 2025, the company had received this work order from the State Project Director, Bihar Education Project Council for the implementation of education quality enhancement in Bihar under PM SHRI.

<a href="https://www.moneycontrol.com/india/stockpricequote/engineering-heavy/ptcindustries/PTC03" target="_blank">PTC Industries</a>

The company has received a purchase order from the Gas Turbine Research Establishment (GTRE), Defence Research and Development Organisation (DRDO), for ready-to-fit single crystal turbine blades and vanes.

<a href="https://www.moneycontrol.com/india/stockpricequote/refineries/indianoilcorporation/IOC" target="_blank">Indian Oil Corporation</a>

Through an appellate order, the company has received tax relief amounting to Rs 1,102.91 crore on account of issues decided in its favour, as against a contested disputed tax and interest of Rs 1,194.07 crore.

The company will be contesting the balance disputed tax of Rs 91.16 crore before the Income Tax Appellate Tribunal (ITAT).

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/drlalpathlabs/DLP01" target="_blank">Dr Lal Path Labs</a>

The Board of Directors will meet on October 31, 2025, to consider the issuance of bonus shares, along with the financial results for the quarter ended September 2025, and the declaration of a second interim dividend, if any.

<a href="https://www.moneycontrol.com/india/stockpricequote/pesticidesagro-chemicals/bharatrasayan/BR01" target="_blank">Bharat Rasayan</a>

The Board has approved the sub-division of 41,55,268 equity shares of face value Rs 10 each (fully paid-up) into 83,10,536 shares of face value Rs 5 each, and also approved the issue of bonus equity shares in the ratio of 1:1.

Bulk Deals

<a href="https://www.moneycontrol.com/india/stockpricequote/hospitalsmedical-services/thyrocaretechnologies/TT16" target="_blank">Thyrocare Technologies</a>

Promoter Docon Technologies, which held 71.06% stake in Thyrocare Technologies as of September 2025, has offloaded 53.3 lakh shares (10.06% of paid-up equity) at Rs 1,252.03 per share, amounting to Rs 667.7 crore.

ICICI Prudential Mutual Fund, HSBC Mutual Fund Midcap Fund, HDFC Mutual Fund, Aditya Birla Sun Life Mutual Fund, and Eastspring Investments India Consumer Equity Open acquired 42.1 lakh shares (7.9% stake) at Rs 1,252 per share, totaling Rs 527.2 crore.

ICICI Prudential Mutual Fund, through its ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund, already held a 2.2% stake in Thyrocare. With the additional purchase of 3.3% shares on Friday, its total shareholding may reach 5.5%.

<a href="https://www.moneycontrol.com/india/stockpricequote/specialty-miningmetals/midwest/ML12" target="_blank">Midwest</a>

Goldman Sachs Funds – Goldman Sachs India Equity Portfolio acquired 4.34 lakh shares (1.2% stake) in Midwest at Rs 1,152.56 per share, for a total consideration of Rs 50.05 crore.

Stocks Trade Ex-Dividend

Infosys
L&amp;T Technology Services
REC
360 ONE WAM
Central Bank of India
CESC
CRISIL
PCBL Chemical
Tanla Platforms

Stocks in F&amp;O ban

SAIL
Sammaan Capital

Disclaimer: MoneyControl is a part of the Network18 group. Network18 is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.

Stocks to Watch Today: Coforge, NCC, Kotak Bank, GPT Infra, Vikran Engineering, Eclerx, Container Corporation, RailTel, Thyrocare, IOC in focus on 27 October

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, appointments and order wins, here’s a quick look at which stocks will be in focus in today's trade:

Results Today

Indus Towers, Indian Oil Corporation, Adani Energy Solutions, Bata India, Canara HSBC Life Insurance Company, Canara Robeco Asset Management Company, Chennai Petroleum Corporation, Glottis, JK Tyre &amp;amp; Industries, KFin Technologies, Mahindra Logistics, Mazagon Dock Shipbuilders, PNB Housing Finance, Raymond, Sona BLW Precision Forgings, SRF, Supreme Industries, Tata Investment Corporation, Tamil Nadu Newsprint &amp;amp; Papers, and Welspun Specialty Solutions will release their quarterly earnings today.

Quarterly Earnings

Kotak Mahindra Bank Q2 (Standalone YoY)

Profit falls 2.7% to Rs 3,253.3 crore Vs Rs 3,343.7 crore

Net interest income rises 4.1% to Rs 7,310.7 crore Vs Rs 7,019.6 crore

Provisions and contingencies spike 43.5% to Rs 947.4 crore Vs Rs 660.4 crore

Gross NPA drops to 1.39% Vs 1.48% (QoQ)

Net NPA declines to 0.32% Vs 0.34% (QoQ)

Dr Reddy's Laboratories Q2 (Consolidated YoY)

Profit grows 14.5% to Rs 1,437.2 crore Vs Rs 1,255.3 crore

Revenue increases 9.8% to Rs 8,805.1 crore Vs Rs 8,016.2 crore

North America business drops 13.1% to Rs 3,240.8 crore Vs Rs 3,728.1 crore

SBI Life Insurance Company Q2 (YoY)

Profit declines 6.6% to Rs 494.6 crore Vs Rs 529.4 crore

Net premium income soars 22.6% to Rs 24,848.3 crore Vs Rs 20,266.1 crore

Net commission surges 22.2% to Rs 1,240.3 crore Vs Rs 1,014.8 crore

Coforge Q2 (Consolidated YoY)

Profit zooms 86% to Rs 375.8 crore Vs Rs 202.1 crore

Revenue surges 31.7% to Rs 3,985.7 crore Vs Rs 3,025.6 crore

Board declares interim dividend of Rs 4 per share

Zen Technologies Q2 (Consolidated YoY)

Profit falls 4.6% to Rs 59.4 crore Vs Rs 62.3 crore

Revenue drops 28.2% to Rs 173.6 crore Vs Rs 241.8 crore

Latent View Analytics Q2 (Consolidated YoY)

Profit grows 11.3% to Rs 44.4 crore Vs Rs 39.9 crore

Revenue increases 23.3% to Rs 257.5 crore Vs Rs 209 crore

Sigachi Industries Q2 (Consolidated YoY)

Profit sinks 50.9% to Rs 10.7 crore Vs Rs 21.8 crore

Revenue declines 11.5% to Rs 110.5 crore Vs Rs 124.9 crore

Supreme Petrochem Q2 (Standalone YoY)

Profit plunges 46.6% to Rs 48.2 crore Vs Rs 90.3 crore

Revenue drops 26.9% to Rs 1,100.2 crore Vs Rs 1,505.6 crore

SBI Cards and Payment Services Q2 (YoY)

Profit rises 10% to Rs 444.8 crore Vs Rs 404.4 crore

Revenue increases 12.2% to Rs 4,961 crore Vs Rs 4,421 crore

eClerx Services Q2 (Consolidated YoY)

Profit zooms 30.6% to Rs 183.2 crore Vs Rs 140.2 crore

Revenue jumps 20.8% to Rs 1,004.9 crore Vs Rs 831.8 crore

Board approves buyback of 6.66 lakh shares worth up to Rs 300 crore at Rs 4,500 per share

Stocks to Watch

Zydus Lifesciences

The company has received a Notice of Compliance (NOC) from Health Canada for generic Mesalamine suppositories 1000 mg. Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis.

Meanwhile, the company’s subsidiary Zydus MedTech France has acquired the remaining 14.4% share capital in Amplitude Surgical SA, France, through a mandatory tender offer and squeeze-out. As a result, Zydus MedTech France now holds 100% of the share capital in Amplitude Surgical.

TGV Sraac

Due to the failure of winding in a transformer supplied by Transformers and Rectifiers India, the company is expecting an estimated loss of production of 120 TPD of caustic soda and 106 TPD of chlorine.

It is further expected that the transformer will be restored within 60 days. The company is also exploring other alternatives for restoration.

NCC

The company has received a Letter of Acceptance for a contract worth Rs 6,828.94 crore from Central Coalfields for the extraction and transportation of overburden (OB) and coal at Amrapali OCP, Chandragupt Area, Jharkhand.

GPT Infraprojects

The company has received an order worth Rs 195 crore from Terminal Industriel Polyvalent de San Pedro, Ivory Coast, for the supply, installation, testing, and commissioning of a conveyor belt system at the Ivory Coast port.

Epack Prefab Technologies

The company has received an order worth Rs 129.94 crore from Avaada Ventures. The order involves the design, fabrication, and supply of a pre-engineered steel building for a glass factory at Butibori, Nagpur, Maharashtra.

Vikran Engineering

The company has received a Letter of Award for a contract worth Rs 354.21 crore from Ellume Energy MH SolarOne (SPV) for the development of a 100 MW (AC) cumulative capacity grid-interactive solar PV power project in Maharashtra.

Housing &amp;amp; Urban Development Corporation

HUDCO has signed a non-binding Memorandum of Understanding (MoU) with the Jawaharlal Nehru Port Authority (JNPA) to explore collaboration in existing and upcoming infrastructure development, and in financing and refinancing of port infrastructure projects at JN Port, for an estimated amount of Rs 5,000 crore.

Reliance Industries

The company’s subsidiary Reliance Intelligence has incorporated Reliance Enterprise Intelligence (REIL). REIL will become a joint venture company as per the amended and restated joint venture agreement with Facebook Overseas, Inc., a wholly owned subsidiary of Meta Platforms, Inc.

As per the JV agreement, Reliance Intelligence will hold 70%, and Facebook will hold the remaining 30% in REIL. Both companies have jointly committed an initial investment of Rs 855 crore.

General Insurance Corporation of India

The Ministry of Finance has approved the entrustment of financial and administrative powers and functions of the Chairman-cum-Managing Director (CMD) of GIC Re to Hitesh Ramesh Chandra Joshi, currently the Executive Director of the company, effective October 1, for a period of three months.

Container Corporation of India

The company has entered into two strategic Memorandums of Understanding (MoUs) with Adani Cement to focus on the rail-based transportation of bulk cement using specialised tank containers.

Puravankara

The company’s subsidiary Starworth Infrastructure &amp;amp; Construction has received a Letter of Award worth Rs 211.53 crore for the construction of core and shell works with finishes for the proposed residential project “SBR Global Queen’s Ville” for SBR Builders.

RailTel Corporation of India

Due to unavoidable reasons, the Bihar Education Project Council has cancelled the work order worth Rs 209.78 crore.

On September 13, 2025, the company had received this work order from the State Project Director, Bihar Education Project Council for the implementation of education quality enhancement in Bihar under PM SHRI.

PTC Industries

The company has received a purchase order from the Gas Turbine Research Establishment (GTRE), Defence Research and Development Organisation (DRDO), for ready-to-fit single crystal turbine blades and vanes.

Indian Oil Corporation

Through an appellate order, the company has received tax relief amounting to Rs 1,102.91 crore on account of issues decided in its favour, as against a contested disputed tax and interest of Rs 1,194.07 crore.

The company will be contesting the balance disputed tax of Rs 91.16 crore before the Income Tax Appellate Tribunal (ITAT).

Dr Lal Path Labs

The Board of Directors will meet on October 31, 2025, to consider the issuance of bonus shares, along with the financial results for the quarter ended September 2025, and the declaration of a second interim dividend, if any.

Bharat Rasayan

The Board has approved the sub-division of 41,55,268 equity shares of face value Rs 10 each (fully paid-up) into 83,10,536 shares of face value Rs 5 each, and also approved the issue of bonus equity shares in the ratio of 1:1.

Bulk Deals

Thyrocare Technologies

Promoter Docon Technologies, which held 71.06% stake in Thyrocare Technologies as of September 2025, has offloaded 53.3 lakh shares (10.06% of paid-up equity) at Rs 1,252.03 per share, amounting to Rs 667.7 crore.

ICICI Prudential Mutual Fund, HSBC Mutual Fund Midcap Fund, HDFC Mutual Fund, Aditya Birla Sun Life Mutual Fund, and Eastspring Investments India Consumer Equity Open acquired 42.1 lakh shares (7.9% stake) at Rs 1,252 per share, totaling Rs 527.2 crore.

ICICI Prudential Mutual Fund, through its ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund, already held a 2.2% stake in Thyrocare. With the additional purchase of 3.3% shares on Friday, its total shareholding may reach 5.5%.

Midwest

Goldman Sachs Funds – Goldman Sachs India Equity Portfolio acquired 4.34 lakh shares (1.2% stake) in Midwest at Rs 1,152.56 per share, for a total consideration of Rs 50.05 crore.

Stocks Trade Ex-Dividend

Infosys
L&amp;amp;T Technology Services
REC
360 ONE WAM
Central Bank of India
CESC
CRISIL
PCBL Chemical
Tanla Platforms

Stocks in F&amp;amp;O ban

SAIL
Sammaan Capital

Disclaimer: MoneyControl is a part of the Network18 group. Network18 is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.

Electronic Goods Industry Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Electronic Goods industry stocks.

Gainers/Losers

Industry Market Map

Earnings Review-Q2 FY25-26

Stock News

Q2 Results impact: SBI Cards shares drop 4% after Sept quarter earnings miss estimates, Zen Tech down 7%

Coforge shares jump 6% as brokerages raise target prices following better-than-expected Q2 results

Zydus Lifesciences gets Health Canada approval, share price unchange

GPT Infraprojects shares surge nearly 13% on order win of Rs 195 crore

Stocks to Watch Today: Coforge, NCC, Kotak Bank, GPT Infra, Vikran Engineering, Eclerx, Container Corporation, RailTel, Thyrocare, IOC in focus on 27 October

Electronic Goods Industry StocksCheck latest stock performance, list of stocks, earnings review & more details about the Electronic Goods industry stocks.

Gainers/Losers

Industry Market Map

Earnings Review-Q2 FY25-26

Stock News

Q2 Results impact: SBI Cards shares drop 4% after Sept quarter earnings miss estimates, Zen Tech down 7%

Coforge shares jump 6% as brokerages raise target prices following better-than-expected Q2 results

Zydus Lifesciences gets Health Canada approval, share price unchange

GPT Infraprojects shares surge nearly 13% on order win of Rs 195 crore

Stocks to Watch Today: Coforge, NCC, Kotak Bank, GPT Infra, Vikran Engineering, Eclerx, Container Corporation, RailTel, Thyrocare, IOC in focus on 27 October

Electronic Goods Industry Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Electronic Goods industry stocks.